Raymond James Financial’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.1M Buy
901,608
+247,278
+38% +$14.5M 0.01% 873
2025
Q4
$40.7M Buy
654,330
+21,022
+3% +$1.3M 0.01% 945
2025
Q3
$38M Sell
633,308
-46,515
-7% -$2.85M 0.01% 979
2025
Q2
$42.6M Sell
679,823
-76,920
-10% -$4.62M 0.01% 852
2025
Q1
$45.5M Buy
756,743
+90,139
+14% +$5.6M 0.02% 767
2024
Q4
$38.9M Buy
+666,604
New +$39.6M 0.01% 875

Other funds holding IHI

Raymond James Financial's IHI Position: Q1 2026 in Review

Raymond James Financial increased its iShares US Medical Devices ETF (IHI) stake by 38% in Q1 2026, buying an estimated $14.5M and bringing the position to 901,608 shares worth $48.1M. The position accounts for 0.01% of the portfolio, ranked #873.

Raymond James Financial first reported a position in IHI in Q4 2024 and has held it in 6 quarters since. 503 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Raymond James Financial held 901,608 shares of iShares US Medical Devices ETF worth $48.1M as of Q1 2026.
  • Raymond James Financial bought 247,278 iShares US Medical Devices ETF shares in Q1 2026, an estimated $14.5M.
  • iShares US Medical Devices ETF made up 0.01% of Raymond James Financial's portfolio in Q1 2026, its #873 holding.
  • Raymond James Financial first reported a position in iShares US Medical Devices ETF in Q4 2024 and has held it in 6 quarters since.
  • 503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.